Q2 2025 Management View CEO Patrick Blair highlighted that InnovAge's Q2 results aligned with expectations, reaffirming FY2025 guidance. He noted progress in revenue growth, margin improvements, and ...

InnovAge Holding Corp reported a 10.6% increase in total revenues for the second quarter of fiscal year 2024, reaching $209 ...

Proximus, Belgium's top mobile network operator, has announced a partnership with BroadForward and technology integrator ...

Zafrens' breakthrough platform allows scientists to create and test hundreds of thousands of potential medicines in a single ...

Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 4,17,628.24 Crore) operating in Pharmaceuticals sector. Sun Pharmaceutical ...

Ozempic is traditionally used as a treatment for type 2 diabetes (T2DM) to help patients manage blood sugar levels. However, ...

Carefully curated defensive strategies can help investors position for potential instability, while capturing return potential in companies that can overcome hurdles ahead. Click to read.